Related Experiment Video
Updated: Aug 18, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Blood component transfusion in primary coronary artery bypass surgery in Kuwait
Fahad Al-Shammari1, Ahmed Al-Duaij, Jamal Al-Fadhli
1Department of Cardiac Surgery, Chest Diseases Hospital, Kuwait. fadawad@yahoo.com
Insights
High rates of blood product transfusion, including packed red blood cells, occurred in primary coronary artery bypass surgery (CABG) patients in Kuwait. These transfusions present significant adverse effect risks and economic costs.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Health Economics
Background:
- Blood product transfusion is common in primary coronary artery bypass surgery (CABG).
- Understanding transfusion rates, influencing factors, and costs is crucial for optimizing patient care and resource allocation.
Purpose of the Study:
- To determine the incidence of blood product transfusion in primary CABG.
- To identify perioperative factors associated with transfusion.
- To assess the economic impact of blood product transfusion in primary CABG.
Main Methods:
- Retrospective review of medical records for 159 consecutive primary CABG patients.
- Data collected included patient demographics, preoperative hemoglobin, transfusion types and volumes, and costs.
- Statistical analysis to identify significant factors associated with transfusion.
Main Results:
- A high transfusion rate of 80.5% was observed, with 70.5% receiving packed red blood cells (RBC).
- Factors associated with intraoperative RBC transfusion included age >60, female gender, low preoperative hemoglobin, and complex grafting.
- The average cost per patient for RBC transfusion was 80 Kuwaiti dinar (USD 240).
Conclusions:
- Primary CABG patients in Kuwait exhibit a high rate of blood component transfusion.
- These transfusions carry potential risks of adverse effects and a substantial economic burden.
- Strategies to reduce transfusion rates may improve patient outcomes and lower healthcare costs.
Objective:
The aims of this study were to determine the rate of blood product transfusion, associated perioperative factors and cost of such blood product transfusion in primary coronary artery bypass surgery (CABG).
Subjects And Methods:
The medical records of 159 consecutive primary CABG patients (142 male, 17 female) from January 1, 2003 to June 30, 2003 at Chest Diseases Hospital, Kuwait, were reviewed. Urgent and emergency cases were included.
Results:
The mean age of the patients was 57.2 (range 36-77 years). Overall, 128 (80.5%) patients received blood product transfusion during primary CABG: 113 (70.5%) packed red blood cells (RBC), 54 (33.9%) fresh frozen plasma, and 13 (8%) platelets. Overall, 23 patients (12.6%) received more than two RBC transfusions intraoperatively. Significant factors for intraoperative RBC transfusion were: age >60 years, female gender, preoperative hemoglobin <12 g/dl, and 3 or more coronary bypass grafts constructed. One hundred and fifty-nine patients consumed 342 units of RBC at an average of 2.1 RBC units per patient. The cost per patient was 80 Kuwaiti dinar (KD; USD 240).
Conclusion:
The findings indicate a high rate of blood component transfusion in primary CABG patients in Kuwait that could expose the patients to the possible adverse effects, and such transfusions have high economic impact.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
